Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company’s products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; and NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain, as well as coma, spinal cord injury, cerebral infarction, hemorrhage, etc. It also provides Carbetocin injections for prevention of postpartum hemorrhage; Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.
तुलना करने के लिए मीट्रिक्स | 002826 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध002826पीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 57.6x | 23.8x | −0.5x | |
PEG अनुपात | 8.51 | 0.03 | 0.00 | |
क़ीमत/बुक | 2.8x | 2.7x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 3.3x | 3.1x | 2.9x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 31.8% | 50.4% | |
उचित मूल्य अपसाइड | अनलॉक करें | 2.2% | 9.1% | अनलॉक करें |